Correspondence 0001193125-25-075712 from Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc.
Date: April 8, 2025 · CIK: 0001782303 · Accession: 0001193125-25-075712
AI Filing Summary & Sentiment
File numbers found in text: 333-286302
Show Raw Text
CORRESP 1 filename1.htm CORRESP Boundless Bio, Inc. 10955 Alexandria Way, Suite 100 San Diego, California 92121 April 8, 2025 VIA EDGAR Doris Stacey Gama Office of Life Sciences Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Boundless Bio, Inc. Registration Statement on Form S-3 File No. 333-286302 To the addressee set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Boundless Bio, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 10, 2025, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Cheston J. Larson of Latham & Watkins LLP at (858) 523-5435. Thank you for your assistance and cooperation in this matter. Sincerely, BOUNDLESS BIO, INC. By: /s/ Jessica Oien Jessica Oien Chief Legal Officer cc: Zachary D. Hornby, Boundless Bio, Inc. Matthew T. Bush, Latham & Watkins LLP Cheston J. Larson, Latham & Watkins LLP